Diagnostic use of circulating cells and sub-cellular bio-particles

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Nanotechnology

Background:

• Circulating cells and sub-cellular bio-particles (e.g., circulating tumor cells, cfDNA, exosomes) are crucial biomarkers in physiological fluids.
• These biomarkers are essential for early disease detection, enabling timely treatment and improving patient outcomes.
• Detecting smaller and less abundant biomarkers necessitates advancements in detection materials and techniques.

Purpose of the Study:

• To define circulating cells and sub-cellular bio-particles, detailing their properties.
• To focus on their diagnostic importance, including biomarker applications and biosensor technologies.
• To discuss current challenges and future prospects in the detection of these biomarkers.

Main Methods:

• Review of existing literature on circulating cells and bio-particles.
• Analysis of diagnostic applications and biosensor technologies.
• Discussion of nanotechnology's role in enhancing detection sensitivity and speed.

Main Results:

• Circulating cells and bio-particles serve as critical indicators for various disorders.
• Nanotechnology is driving the development of more sensitive and efficient biosensors for biomarker detection.
• Progress in understanding biomolecular pathways enhances diagnostic test specificity and thoroughness.

Conclusions:

• Integrating advanced circulating cell and bio-particle diagnostics into clinical practice holds promise for precision medicine.
• Continued technological advancements will lead to more sensitive and specific diagnostic tests.
• Early detection and improved diagnostics through these biomarkers can significantly enhance patient outcomes.